Related Experiment Video
Updated: May 3, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori indyspeptic Nigerians.
A B Olokoba1, E Apari, F K Salawu
1Gastroenterology Unit, Department of Medicine, University of Ilorin Teaching Hospital, P.M.B 1459, Ilorin, Kwara State, Nigeria.
Helicobacter pylori infection is highly prevalent in dyspeptic patients in North-Eastern Nigeria, significantly associated with severe chronic gastritis. This finding highlights the importance of H. pylori detection in this population.
Area of Science:
- Gastroenterology
- Microbiology
- Pathology
Background:
- Dyspepsia is a frequent gastrointestinal disorder and a primary reason for upper gastrointestinal endoscopy.
- Helicobacter pylori (H. pylori) is a key factor in acid peptic diseases and gastric cancer.
- H. pylori detection during endoscopy is standard, yet data from North-Eastern Nigeria is limited.
Purpose of the Study:
- To ascertain the prevalence of H. pylori in dyspeptic patients.
- To investigate the correlation between H. pylori infection and the severity of chronic gastritis.
Main Methods:
- A hospital-based cross-sectional study was conducted from November 2006 to May 2010.
- Endoscopic biopsies from the antral stomach of dyspeptic patients were collected.
- Biopsies were processed for H. pylori detection and histological analysis.
Main Results:
- 349 dyspeptic patients (43.6% male, 56.4% female) underwent endoscopy.
- The prevalence of H. pylori was found to be 56.7%.
- H. pylori infection showed a strong association with severe chronic gastritis (80.3%), moderate (57.5%), and mild (20%) activity.
Conclusions:
- A high prevalence of H. pylori exists among dyspeptic individuals in the study region.
- There is a significant association between H. pylori and chronic gastritis, particularly with severe inflammatory activity.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.